Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aplaviroc in treatment-experienced HIV with R5/X4-tropic virus
NCT00197197Phase 3Terminated
- Sponsor
- GSK
- Start
- Jul 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of aplaviroc in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Jul 2005; status: terminated.
02
Drugs
aplaviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00197197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197197.